IV iron product use, by DOPPS country and cross-section

  Sucrose only Gluconate only Dextran only Other
N Ptnts Wgtd % N Ptnts Wgtd % N Ptnts Wgtd % N Ptnts Wgtd %
DOPPS Country DOPPS Cross-section 7 3.5% 1 0.5% 0 0.0% 188 96.0%
AusNZ D4(2010)
D4(2011) 7 2.7% 1 0.6% 0 0.0% 255 96.7%
Belgium D4(2010) 376 100.0% 0 0.0% 0 0.0% 0 0.0%
D4(2011) 373 100.0% 0 0.0% 0 0.0% 0 0.0%
Canada D4(2010) 132 60.4% 43 10.0% 62 29.6% 0 0.0%
D4(2011) 184 60.1% 73 15.0% 67 24.9% 0 0.0%
France D4(2010) 191 64.1% 0 0.0% 33 20.9% 40 15.1%
D4(2011) 200 62.0% 1 0.2% 36 18.5% 59 19.4%
Germany D4(2010) 47 10.0% 336 81.5% 31 5.2% 16 3.3%
D4(2011) 61 11.9% 379 81.5% 26 4.0% 16 2.7%
Italy D4(2010) 0 0.0% 350 90.6% 0 0.0% 34 9.4%
D4(2011) 0 0.0% 413 95.2% 0 0.0% 18 4.8%
Japan D4(2010) 0 0.0% 0 0.0% 0 0.0% 575 100.0%
D4(2011) 0 0.0% 0 0.0% 0 0.0% 621 100.0%
Spain D4(2010) 390 85.8% 1 0.2% 1 0.2% 74 13.9%
D4(2011) 365 88.2% 3 0.7% 1 0.2% 59 11.0%
Sweden D4(2010) 316 92.6% 0 0.0% 30 7.4% 0 0.0%
D4(2011) 318 91.9% 0 0.0% 34 8.1% 0 0.0%
UK D4(2010) 259 93.9% 0 0.0% 27 6.1% 0 0.0%
D4(2011) 331 94.4% 0 0.0% 27 5.2% 2 0.3%
US D4(2010) 2,094 86.1% 185 8.8% 7 0.4% 46 4.7%
D4(2011) 2,744 91.6% 234 8.0% 22 0.4% 0 0.0%

Medications reported as prescribed in previous three months, among all patients

Please see additional methodological information in the Data Sources and Methods section.